Efficacy of Rapid Antigen Self-testing for SARS-CoV-2 Screening: Real-world Evidence from a Prospective Cohort Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Larremore D, Wilder B, Lester E, Shehata S, Burke J, Hay J
. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2020; 7(1).
PMC: 7775777.
DOI: 10.1126/sciadv.abd5393.
View
2.
Garcia-Finana M, Hughes D, Cheyne C, Burnside G, Stockbridge M, Fowler T
. Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ. 2021; 374:n1637.
PMC: 8259455.
DOI: 10.1136/bmj.n1637.
View
3.
Drain P
. Rapid Diagnostic Testing for SARS-CoV-2. N Engl J Med. 2022; 386(3):264-272.
PMC: 8820190.
DOI: 10.1056/NEJMcp2117115.
View
4.
Zhang X, Barr B, Green M, Hughes D, Ashton M, Charalampopoulos D
. Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study. BMJ. 2022; 379:e071374.
PMC: 9682337.
DOI: 10.1136/bmj-2022-071374.
View